Integra LifeSciences
(NASDAQ) IART
Integra LifeSciences Financials at a Glance
Market Cap
$1.36BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$1.64B
Net Income (TTM)
-$495.80M
EPS (TTM)
-$6.46
P/E Ratio
-2.70
Dividend
$0.00
Beta (Volatility)
1.10 (Average)
Dividend
$0.00
Beta (Volatility)
1.10 (Average)
Price
$17.51
Volume
30.143
Open
$18.75
Price
$17.51
Volume
30.143
Open
$18.75
Previous Close
$17.46
Daily Range
$17.31 - $18.75
52-Week Range
$8.70 - $18.92
Estimated Earnings Date
Jul 30, 2026
Dividend
$0.00
Beta (Volatility)
1.10 (Average)
Price
$17.51
Volume
30.143
Open
$18.75
Previous Close
$17.46
Daily Range
$17.31 - $18.75
52-Week Range
$8.70 - $18.92
Estimated Earnings Date
Jul 30, 2026
IART News
Integra Beats on the Bottom Line
IART: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Integra LifeSciences
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
4,427
CEO
Mojdeh Poul, MBA
Website
www.integralife.comHeadquarters
Princeton, NJ 08540, US
IART Financials
Key Financial Metrics (TTM)
Gross Margin
53.21%
Operating Margin
7.53%
Net Income Margin
-30.15%
Return on Equity
-47.65%
Return on Capital
2.22%
Return on Assets
-13.86%
Earnings Yield
-37.04%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.36BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
77.80M
Volume
30.143
Avg. Volume
1.01M
Financials (TTM)
Gross Profit
$875.04M
Operating Income
$123.90M
EBITDA
-$289.30M
Operating Cash Flow
$71.44M
Capital Expenditure
-$81.57M
Free Cash Flow
-$10.12M
Cash & ST Invst.
$265.50M
Total Debt
$2.04B
Integra LifeSciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$391.92M
+2.4%
Gross Profit
$224.24M
+15.3%
Gross Margin
57.22%
N/A
Market Cap
$1.36BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$308.99K
N/A
Employees
4,396
N/A
Net Income
-$4.62M
+81.7%
EBITDA
$62.87M
+142.1%
Quarterly Fundamentals
Total Cash
$265.50M
-2.9%
Total Debt
$2.04B
+1.0%
Accounts Receivable
$264.41M
+4.7%
Inventory
$495.04M
+11.1%
Long Term Debt
$1.99B
+42.7%
Short Term Debt
$52.68M
-91.6%
Return on Assets
-13.86%
N/A
Return on Invested Capital
3.83%
N/A
Free Cash Flow
-$5.05M
+87.4%
Operating Cash Flow
$9.80M
+187.1%